Chemotherapy Current Events | Chemotherapy News | 10
|
| Page
10 of
25 |
498 Results |
|
|
|
Sort By:
Page Views | Date |
Moores UCSD Cancer Center studying novel leukemia vaccine for high-risk patients
Researchers at the Moores Cancer Center at the University of California, San Diego (UCSD) are conducting clinical trials of a novel therapy aimed at revving up the immune system to combat a particularly difficult-to-treat form of leukemia. view more (2008-11-04)
Inherited genes linked to toxicity of leukemia therapy
Investigators at St. Jude Children's Research Hospital have discovered inherited variations in certain genes that make children with acute lymphoblastic leukemia (ALL) susceptible to the toxic side effects caused by chemotherapy medications. view more (2007-05-14)
Herceptin gives disappointing results in lung cancer trial
Trastuzumab (Herceptin) - a treatment that has increased survival in many breast cancer patients - has failed to live up to hopes that it might also help lung cancer patients. view more (2004-01-08)
New hope for patients with chronic lymphocytic leukemia
Patients treated with lenalidomide for relapsed chronic lymphocytic leukemia (CLL) or disease that no longer responds to chemotherapy have experienced a major response to therapy, according to a phase II study conducted by Asher Chanan-Khan, MD, Department of Medicine, Roswell Park Cancer Institute (RPCI). The results are published in the December... view more... (2006-12-05)
Studies show novel device may enhance chemotherapy treatment in brain tumors
NovoCure Ltd. presented results yesterday evaluating the Novo-TTF device in vitro and in a pilot clinical trial that showed the device enhanced the efficacy of standard chemotherapy (temozolomide) treatment in newly-diagnosed glioblastoma multiforme (GBM) patients. view more (2008-11-25)
Exercise and yoga improves quality of life in women with early-stage breast cancer
Two studies report that exercise and yoga can help maintain and in some cases improve quality of life in women with early-stage breast cancer. view more (2007-09-05)
Hypertension and cholesterol medications present in water released into the St. Lawrence River
A study conducted by Université de Montréal researchers on downstream and upstream water from the Montreal wastewater treatment plant has revealed the presence of chemotherapy products and certain hypertension and cholesterol medications. view more (2009-01-27)
Chemo-radiation before prostate removal may prevent cancer recurrence
Researchers in the Oregon Health & Science University Knight Cancer Institute and the Portland Veterans Affairs Medical Center have found a combination of radiation therapy and chemotherapy given before prostate removal is safe and may have the potential to reduce cancer recurrence and improve patient survival. view more (2009-11-05)
Cost-benefit analysis: Combo treatment costs more, saves money later
From a health insurer's perspective, the most effective cancer treatment may also be the most cost-effective. view more (2006-11-08)
Anemic children with cancer benefit from erythropoietin
Children with cancer who develop anemia during chemotherapy can benefit from a weekly dose of erythropoietin (EPO), according to researchers at St. Jude Children's Research Hospital. view more (2006-07-28)
FDG-PET Imaging Clearly Predicts Lung Cancer Patients' Response to Chemotherapy
An earlier indication of whether chemotherapy benefits non-small cell lung cancer patients—provided by positron emission tomography (PET) imaging—can guide doctors in offering them better care, according to researchers in the May Journal of Nuclear Medicine. view more (2007-05-10)
Northwestern researchers launch Avastin trial for pancreatic tumors
Avastin is designed to inhibit Vascular Endothelial Growth Factor (VEGF), a protein that plays an important role in tumor angiogenesis or blood vessel formation, and maintenance of existing tumor vessels. view more (2006-02-22)
Protein shines light on cancer response
A technique that specifically "tags" tumors responding to chemotherapy may offer a new strategy for determining a cancer treatment's effectiveness within days of starting treatment, according to a new study by Vanderbilt-Ingram Cancer Center investigators. view more (2008-02-25)
Biodegradable gel being studied as a treatment for esophageal cancer
Gastroenterologists at Rush University Medical Center are studying the safety and efficacy of a new system for delivering chemotherapy for patients with esophageal cancer, a rare, but deadly disease that attacks the throat. view more (2009-04-16)
Study suggests that trouble sleeping leads to increased ratings of pain in cancer patients
A study in the April 15 issue of the Journal of Clinical Sleep Medicine suggests that sleep problems lead to increased pain and fatigue in cancer patients. The results indicate that interventions aimed at trouble sleeping would be expected to improve both pain and fatigue in this patient population. view more (2009-04-15)
A novel mechanism of action for anti-tumor agent, CA4P
Anti-angiogenic agents have been successful in the clinic for blocking the growth of solid tumors. However, these agents used in combination with chemotherapy have improved the survival of patients with cancers by only several months. view more (2005-10-07)
Fertility procedures need not delay breast cancer treatment for younger women
A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion. view more (2009-11-13)
New discovery leaves blood-doping athletes scratching their heads
A stunning discovery by German scientists may make blood doping and the treatment of severe anemia as easy as washing your hair. view more (2007-09-21)
Adding epratuzumab to standard therapy
Adding a second monoclonal antibody drug to chemotherapy looks promising for treatment of diffuse large B-cell lymphoma. view more (2008-05-16)
Stem cell indicator for bowel cancer should lead to better survival rates
Stem cell scientists have developed a more accurate way of identifying aggressive forms of bowel cancer, which should eventually lead to better treatment and survival rates. Bowel cancer is the third most common cancer in the UK. view more (2008-08-20)
|
|
| Page
10 of
25 |
498 Results |
|
|
|
Sort By:
Page Views | Date |
|
